Primary Medical Management of Recurrent Aggressive Angiomyxoma of the Vulva with a Gonadotropin-Releasing Hormone Agonist

Author： Fine B.A. Munoz A.K. Litz C.E. Gershenson D.M.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.81, Iss.1, 2001-04, pp. : 120-122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer

By Anderson John

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 433-443

Future Medicine

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi Vici Patrizia Medico Pietro Laudadio Lucio Tomao Silverio Giannarelli Diana Pizzuti Laura Sergi Domenico Barba Maddalena Maugeri-Saccà Marcello

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell Line

By Shibata S. Sato H. Ota H. Karube A. Takahashi O. Tanaka T.

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Cell Cycle Arrest in Endometrial Carcinoma Cells Exposed to Gonadotropin-Releasing Hormone Analog

By Kim J.W. Lee Y.S. Kim B.K. Park D.C. Lee J.M. Kim I.K. Namkoong S.E.

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 368-371

Elsevier

Access to resources Recommend Favorite

Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric Data

By Agorastos T. Bontis J. Vakiani A. Vavilis D. Constantinidis T.

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 102-114

Elsevier

Access to resources Recommend Favorite